Offer summary

Qualifications:

Clinical and/or scientific experience in a research setting required., Knowledge of FDA guidelines and GCP is essential., Research certification (ACRP or CCRP) preferred., Strong analytical abilities and problem-solving skills in a fast-paced environment..

Key responsabilities:

Oversee overall study activation activities and supervise staff.

Liaise with site, sponsor, and CRO contacts to maintain organizational connectivity.

Drive improvement strategies for trial activations and manage relationships with sites and partners.

Facilitate business development and relationship management activities with pending and active sites.

Job description

It’s More Than a Career, It’s a Mission.

Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

Our Mission

People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.

As the Manager of Study Activation you will be responsible for overall study activation activities, including direct supervision and development of staff, adherence to standard operating procedures and reporting of data to internal and external groups. You will provide leadership in the study start-up, to include trials in lead, opportunity and selection.

You will oversee the study activation team
You will liaise with site, sponsor and CRO contacts to establish and maintain key organizational connectivity through study start-up
You will support the overall site evaluation process from review of opportunity to executive leadership recommendation
You will interface with Sarah Cannon lines of business to develop/foster relationships and understanding of business line needs in order to provide high level service and appropriate site collaboration
You will facilitate business development and relationship management activities with pending and active sites and pharma/CRO partners
You will utilize metrics to drive improvement strategies trial activations for sites and site, sponsor and CRO partner relationships
You will appropriately escalate unresolved issues to Senior Manager or appropriate level of management
You will drive new initiatives and special projects, as directed by Senior Manager, Site Relationships and Support Services
You will provide oversight, leadership, and direction in the study startup of trials and in maintenance areas where support is provided
You will assess organizational processes associated with startup and support to identify ways to improve and streamline processes
You will meet with site leadership as needed to ensure contracted services are being provided by the teams

You should have for this position:

The ability to read, understand, and comply with research protocols.
Knowledge of FDA guidelines and GCP.
Resourceful with heightened analytical abilities and problem solving skills in a fast paced environment.
Excellent interpersonal skills, detailed-oriented and meticulous.
Clinical and/or scientific experience in a research setting required
Research certification (ACRP or CCRP) preferred

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings.

We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.

As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.

We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Required profile